SSR 4月节点 2025

The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.

Announcing our new Impact Factor: 5.615

July 2025
Read the July issue!
First Disclosure: MMAE Delivery Using the Bicycle Toxin Conjugate BT5528
Gavin Bennett, et al.
The Dysregulated Pharmacology of Clinically Relevant ESR1 Mutants is Normalized by Ligand-activated WT Receptor
Kaitlyn J. Andreano, et al.
Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734
Chevaun D. Morrison-Smith, et al.

SSR 4月节点 2025

Small Molecule Therapeutics | AuthorChoice

MMAE Delivery Using the 网际直通车 Toxin Conjugate BT5528

Gavin Bennett, Amy Brown, Gemma Mudd, Philip Huxley, Katerine Van Rietschoten, Silvia 网际直通车, 网际直通车 Chen, Sophie Watcham, Johanna Lahdenranta and 网际直通车 Keen

Mol Cancer Ther July 1 2025 19 (7) 1385-1394; DOI:10.1158/1535-7163.MCT-19-1092
Large Molecule Therapeutics

Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3

Alexander Rau, Wolfgang S. Lieb, Oliver Seifert, Jonas Honer, Dennis Birnstock, Fabian Richter, Nadine Aschmoneit, Monilola A. Olayioye and Roland E. Kontermann

Mol Cancer Ther July 1 2025 19 (7) 1474-1485; 中国行业云安全PCSF论坛推动私有云等级保护升级－企业 ...:2021-10-26 · 联系我伞邮箱登录通行证登录网站地图
Companion Diagnostic, Pharmacogenomic, and Cancer Biomarkers | AuthorChoice

高清盗版风暴：大年初三，我已经下载好全部春节档电影 ...:2021-4-29 · 8年前，知名盗版网站VeryCD一度传出关停消息，曾引起大量网友涌入网站，希望抢在关停前把资源都下载下来。8年后，《流浪地球》主创的微博下，网友的留言却变成了举报盗版链接。“每天都有观伡给我伞发来的私信，协助我伞打击盗版。这是我最没想到的，非常感动。

Andrew A. Davis, Wade T. Iams, David Chan, Michael S. Oh, Robert W. Lentz, Neil Peterman, Alex 网际直通车, Abhik Shah, Rohith Srivas, Timothy J. Wilson, Nicole J. Lambert, Peter S. 网际直通车, Becky Wong, Haleigh W. Wood, 网际直通车 Close, Ayse Tezcan, Ken Nesmith, Haluk Tezcan and Young Kwang Chae

网际直通车 July 1 2025 19 (7) 1486-1496; DOI:10.1158/1535-7163.MCT-19-1060
Cancer Biology and Translational Studies

Functional miRNA Screening Identifies Wide-ranging Antitumor Properties of miR-3622b-5p and Reveals a New Therapeutic Combination Strategy in Ovarian Tumor Organoids

Mégane Vernon, Bernard Lambert, Matthieu Meryet-Figuière, Emilie Brotin, Louis-Bastien Weiswald, Hippolyte Paysant, Nicolas Vigneron, Anaïs Wambecke, Edwige 网际直通车, 网际直通车 Giffard, Marie-Hélène Louis, Cécile Blanc-Fournier, Pascal Gauduchon, Laurent 网际直通车 and Christophe Denoyelle

Mol Cancer Ther July 1 2025 19 (7) 1506-1519; DOI:10.1158/1535-7163.MCT-19-0510

See the Table of Contents

SSR 4月节点 2025

网际直通车

A Historic Perspective and Overview of H-Ras Structure, Oncogenicity, and Targeting

Lihua Shu, Dongsheng Wang, Nabil F. Saba and Zhuo G. Chen

Mol Cancer Ther April 1 2025 19 (4) 999-1007; DOI:10.1158/1535-7163.MCT-19-0660
Review

The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer

Scott F. Schoninger and Stacy W. Blain

Mol Cancer Ther January 1 2025 19 (1) 3-12; DOI:10.1158/1535-7163.MCT-19-0253
Review | AuthorChoice

Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence

Paulo Bergerot, 网际直通车 Lamb, Evelyn Wang and Sumanta K. Pal

Mol Cancer Ther December 1 2025 18 网际直通车2185-2193; DOI:10.1158/1535-7163.MCT-18-1399
Reviews | AuthorChoice

ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications

Samantha A. Armstrong, Christopher W. Schultz, Ariana Azimi-Sadjadi, Jonathan R. Brody and Michael J. Pishvaian

Mol Cancer Ther November 1 2025 18 (11) 1899-1908; DOI:10.1158/1535-7163.MCT-19-0208

网际直通车

SSR 4月节点 2025

mTOR blockade arrests tumors, increases let7, decreases CDK6
Joy Gary, et al.
Predictive and prognostic biomarkers for regorafenib
Yingmiao Liu, et al.
TMB and Overall Survival
Paul Riviere, et al.
周刊 - chinacourt.org:2021-10-24 · 群伡反映问题，开通民意网上直通车。黑龙江高院还制定了《“院长信箱”所涉案件、事项办理工作的实施细则》，规范信箱留言的梳理、批转、办理和答复等流程。目前，全省三级法院192个法院网站都开通了 “院长信箱”，极大地方便了当事人反映诉求。
网际直通车 Rago, et al.